← All trials
NCT00252304
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2006
- Primary completion
- Jul 1, 2008
- Completion date
- Jul 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 641
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of BergenLead sponsor
- Tribhuvan UniversityOverall official - principal investigator
- University of BergenStudy director
- University of BergenStudy chair
- Institute of Medicine, MaharajganjStudy director
- Institute of Medicine, MaharajganjStudy chair
- Statens Serum InstitutCollaborator
- Society for Applied Studies, New DelhiCollaborator
- Tribhuvan UniversityCollaborator
- All India Institute of Medical SciencesCollaborator
- Government of FranceCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.